These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7059462)

  • 1. Response of a high-glucuronidase human tumour xenograft to aniline mustard.
    Warenius HM; Workman P; Bleehen NM
    Br J Cancer; 1982 Jan; 45(1):27-34. PubMed ID: 7059462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new high-glucuronidase mouse tumor curable by aniline mustard therapy.
    Double JA; Workman P
    Cancer Treat Rep; 1977 Aug; 61(5):909-11. PubMed ID: 890696
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced cytostatic effectiveness of aniline mustard against 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors during regression in response to ovariectomy.
    Benckhuysen C; Ter Hart HG; Van Dijk PJ
    Cancer Treat Rep; 1981; 65(7-8):567-74. PubMed ID: 6788369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell beta-glucuronidase activity.
    Young CW; Yagoda A; Bittar ES; Smith SW; Grabstald H; Whitmore W
    Cancer; 1976 Nov; 38(5):1887-95. PubMed ID: 991104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucuronic acid conjugate of aniline mustard on human ovarian and other tumours 'in vitro'.
    Rao KV; Bhat AV; Bapat CV
    Indian J Cancer; 1978 Sep; 15(3):21-2. PubMed ID: 575105
    [No Abstract]   [Full Text] [Related]  

  • 6. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.
    Warenius HM; Freedman LS; Bleehen NM
    Br J Cancer Suppl; 1980 Apr; 4():128-32. PubMed ID: 6932916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of aniline mustard glucuronide alone or in a combination with glucose in Walker cells in culture and sarcoma-180 tumour bearing animals.
    Deliconstantinos G; Ramantanis G; Todorou DK
    Biomed Pharmacother; 1983; 37(7):339-43. PubMed ID: 6667340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency.
    Warenius HM; Bleehen NM
    Br J Cancer; 1982 Jul; 46(1):45-50. PubMed ID: 7104196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
    Begleiter A; Blair GW
    Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rutin-N-mustard on the survival of NK/Ly ascites tumour-bearing mice.
    Molnár J; Mucsi I; Mándi Y; Béládi I; Földeák S; Boda K
    Int J Cancer; 1982 Dec; 30(6):767-71. PubMed ID: 6897647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restorative effects of levamisole on cell-mediated immune responses following chemotherapy with aniline mustard in mice bearing ADJ-PC5 plasmacytoma.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW
    Cancer Treat Rep; 1978 Nov; 62(11):1627-35. PubMed ID: 310338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cortiphen on human tumor strains transplanted into athymic mice and rats].
    Bukharova IK; Revazova ES; Moroz LV
    Eksp Onkol; 1990; 12(1):66-8. PubMed ID: 2298147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of a synthetic peptide on some syngeneic tumors].
    Pugliese A; Negro Ponzi A
    G Batteriol Virol Immunol; 1975; 68(7-12):231-9. PubMed ID: 1234591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid aza-steroid alkylators in the treatment of colon cancer.
    Trafalis DT
    Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug.
    Cheng TL; Wei SL; Chen BM; Chern JW; Wu MF; Liu PW; Roffler SR
    Br J Cancer; 1999 Mar; 79(9-10):1378-85. PubMed ID: 10188879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of mice bearing advanced plasma cell tumours with aniline mustard.
    Whisson ME; Connors TA
    Nature; 1965 May; 206(985):689-91. PubMed ID: 5832853
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies on the anti-neoplastic activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [p-[bis(2-chloroethyl)amino]-phenyl]acetate (NSC 290205).
    Catsoulacos P
    Cancer Lett; 1984 Mar; 22(2):199-202. PubMed ID: 6704948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft.
    Stribbling SM; Martin J; Pedley RB; Boden JA; Sharma SK; Springer CJ
    Cancer Chemother Pharmacol; 1997; 40(4):277-84. PubMed ID: 9225945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemistry of therapeutically relevant enzymes in human tumours transplanted into severe combined immunodeficient (SCID) mice: nitric oxide synthase-associated diaphorase, beta-D-glucuronidase and non-specific alkaline phosphatase.
    Schumacher U; Adam E; Zangemeister-Wittke U; Gossrau R
    Acta Histochem; 1996 Nov; 98(4):381-7. PubMed ID: 8960302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.